
Study to evaluate impact of ArteraAI on clinical decision-making for prostate cancer
Artera has announced the launch of the DIRECT-AI registry, which will assess the influence of the ArteraAI Prostate Test on treatment decisions for patients with localized prostate cancer.1,2 The ArteraAI Prostate test is a multimodal artificial …